Skip to content

Upstream Bio, Inc. UPB Earnings yield

Earnings yield at other companies

Amgen logo
AmgenAMGN
4.1%+0.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-15.3%-6.8pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-10.8%-5.2pp
Savara logo
SavaraSVRA
-11.6%-3.6pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-9.9%-2.8pp

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s earnings yield?
Upstream Bio, Inc. (UPB) reported earnings yield of -32% in Q1 2026.
How has Upstream Bio, Inc.'s earnings yield changed year-over-year?
Upstream Bio, Inc.'s earnings yield decreased by 32.7% year-over-year, from -24.1% to -32%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.